Political Quotes

On the recordJanuary 4, 2017
I demand a recorded vote. A recorded vote was ordered. The SPEAKER pro tempore. This is a 5-minute vote. The vote was taken by electronic device, and there were--ayes 238, noes 184, not voting 11, as follows: [Roll No. 8] AYES--238 Abraham Aderholt Allen Amash Amodei Arrington Babin Bacon Banks (IN) Barletta Barr Barton Bergman Beutler Biggs Bilirakis Bishop (MI) Bishop (UT) Black Blackburn Blum Bost Brady (TX) Brat Bridenstine Brooks (AL) Brooks (IN) Buchanan Buck Bucshon Budd Burgess Byrne Calvert Carter (GA) Carter (TX) Chabot Chaffetz Cheney Coffman Cole Collins (GA) Comer Comstock Conaway Cook Costello (PA) Cramer Crawford Cuellar Culberson Curbelo (FL) Davidson Davis, Rodney Denham Dent DeSantis DesJarlais Diaz-Balart Donovan Duffy Duncan (SC) Duncan (TN) Dunn Emmer Farenthold Faso Ferguson Fitzpatrick Fleischmann Flores Fortenberry Foxx Franks (AZ) Frelinghuysen Gaetz Gallagher Garrett Gibbs Gohmert Goodlatte Gosar Gottheimer Gowdy Granger Graves (GA) Graves (LA) Graves (MO) Griffith Grothman Guthrie Harper Harris Hartzler Hensarling Hice, Jody B.…
Said by
John Conyers
Democratic · Michigan
Source
govinfo.gov
Jan 4, 2017

Share

More from John Conyers

Sep 27, 2017

The title is Serious Risks Presented by the Anti-Regulatory Agenda of the 115th Congress and the Trump administration.

congress.gov
Oct 25, 2017

Although H.R. 469 has many flaws, I am particularly concerned that the bill's broad and ill-defined requirements would effectively delay and possibly deter civil enforcement agencies from providing general relief in discrimination cases…

govinfo.gov
Jul 26, 2017

We should of course remain vigilant about pay-for-delay schemes, whereby branded drug manufacturers pay generic manufacturers to delay the entry of a version of branded drugs as the patent on the branded drug expires.

congress.gov
Oct 31, 2017

This committee has marked up legislation that would unfortunately implement President Trump's vision for mass deportation.

congress.gov

Other voices in this conversation